ArticleBiomolecules & biomedicine2026
Development and validation of a predictive risk model for post-stroke deep vein thrombosis.
Article in Biomolecules & biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep vein thrombosis (DVT) represents a common and potentially fatal complication following acute ischemic stroke (AIS). However, early risk stratification is often difficult due to the asymptomatic nature of post-stroke DVT and the scarcity of AIS-specific predictive instruments. This study aimed to develop a nomogram utilizing baseline patient characteristics to forecast DVT risk after AIS. In this retrospective study, 848 AIS patients were analyzed, with 79 subsequently developing DVT. Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariable logistic regression identified five independent predictors: age (odds ratio [OR] = 1.074), fibrinogen (OR = 1.700), D-dimer (OR = 1.123), platelet count (OR = 1.001), and sex (OR = 0.475). A predictive nomogram was then constructed based on these variables. The model achieved an initial area under the receiver operating characteristic curve (AUC) of 0.809 and a Brier score of 0.074. Internal validation, conducted via 1,000-resample bootstrapping, yielded a stable optimism-corrected AUC of 0.800. Calibration plots demonstrated excellent concordance between predicted probabilities and observed outcomes. Decision curve analysis (DCA) indicated a positive net clinical benefit across a threshold probability range of 1%-91%, encompassing the clinically relevant 5%-20% decision window. In conclusion, this study successfully developed an exploratory nomogram for the early estimation of DVT risk in patients with AIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.